"Here we are a number of years later ... the Midkine assets are not being developed, their value just depreciating away and have now been put on the block for sale - because they have proven to be too hard for this Board to make use of".
With regular appearances of new patents being granted for various treatments of major life threatening cancers and also of confirming peer reviewed research carried out over many years in various respected journals I find it a tad hard to relate to your assessment that MK is not being developed.
As far as being put on the block for sale I remain convinced that the idea is to sell an exclusive licence to access the MK patents via upfront and royalty payments with the patents to remain in CDY hands and the access licence to be in Lyramids hands.
- Forums
- ASX - By Stock
- AN1
- Amazon
Amazon, page-12
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable